You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Diagnosis and Optimal Treatment for Systemic Lupus Erythematosus and Lupus Nephritis

  • Authors: Salam Almanni, MD, MS; Dawn Caster, MD, FASN; Juan Mejia-Vilet, MD, MSc, PhD
  • CME / ABIM MOC / CE Released: 9/26/2022
  • Valid for credit through: 9/26/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.50 ABIM MOC points

    Pharmacists - 1.50 Knowledge-based ACPE (0.150 CEUs)

    Nurse Practitioners - 1.50 AANP Contact Hours (0.25 contact hours are in the area of pharmacology)

    Physician Assistant - 1.50 AAPA hour(s) of Category I credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

The target audiences for this activity include pharmacists; physicians; physician assistants; nurses and nurse practitioners; dietitians; social workers; dialysis technicians; and transplant coordinators involved in the specialties of primary care, rheumatology, and nephrology.

The goal of this session is that the learner will be better able to provide expert guidance on effective individualized decision-making for patients with lupus nephritis.

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of variable severity and symptom presentation that affects multiple organs in the body. The waxing and waning nature of the disease course between flares and remission requires careful management by physicians, and patients must take an active role in self-care; the involvement of different organs means that care of patients must be multidisciplinary to be effective. This panel of expert faculty will discuss identification, classification, and management of patients with lupus nephritis within the context of the overall disease and other organ manifestations.

Upon completion of this activity, participants will:

  • Use treatment plans for patients with different organ manifestations of SLE based on current guidelines and new and emerging clinical trial data
  • Identify patients at high risk of organ-specific disease flare and apply strategies to mitigate risk and proactively reinitiate treatment
  • Review the factors affecting prognosis of patients with lupus nephritis, including the impact of ethnicity and health disparities
  • Apply evidence-based pharmacotherapeutic strategies for class III and class IV lupus nephritis, and discuss treatment approaches for class V


Faculty

  • Salam Almanni, MD, MS

    Assistant Professor
    Ohio State University
    Columbus, Ohio

    Disclosures

    Disclosure: Salam Almanni, MD, MS, has the following relevant financial relationships:
    Research funding from: Gilead
    Other: Honoraria: Aurinia Pharmaceuticals; Kezar

  • Dawn Caster, MD, FASN

    Assistant Professor
    University of Louisville
    Louisville, Kentucky

    Disclosures

    Disclosure: Dawn Caster, MD, FASN, has no relevant financial relationships.

  • Juan Mejia-Vilet, MD, MSc, PhD

    Head, Glomerular Diseases Clinic
    Department of Nephrology and Mineral Metabolism
    National Medical Sciences and Nutrition Institute Salvador Zubiran
    Mexico City, New Mexico

    Disclosures

    Disclosure: Juan Mejia-Vilet, MD, MSc, PhD, has the following relevant financial relationships:
    Consultant or advisor for: GlaxoSmithKline; Kezar
    Other: Honoraria: Boehringer Ingelheim; Roche

Planning Committee Disclosures

  • Tara Chang, MD, MS

    Physician
    Stanford University
    School of Medicine
    Palo Alto, California

    Disclosures

    Disclosure: Tara Chang, MD, MS, has the following relevant financial relationships:
    Consulting Fee: Bayer, Gilead, Novo Nordisk, Tricida

  • Jo Ann Otts, DNP, RN, NEA-BC, CENP, FNKF

    Assistant Professor
    University of South Alabama
    Mobile, Alabama

    Disclosures

    Disclosure: Jo Ann Otts, DNP, RN, NEA-BC, CENP, FNKF, has no relevant financial relationships.

  • Elizabeth Jones, MSW, LCSW, FNKF

    Social Worker
    DaVita
    Fairfax Station, Virginia

    Disclosures

    Disclosure: Elizabeth Jones, MSW, LCSW, FNKF, has no relevant financial relationships.

  • Marlene Shaw-Gallagher, PA-C

    Physician Assistant
    University of Michigan Health System
    Livonia, Michigan

    Disclosures

    Disclosure: Marlene Shaw-Gallagher, PA-C, has no relevant financial relationships.

  • Melissa Prest, DCN, RDN

    Foundation Dietitian
    National Kidney Foundation of Illinois
    Chicago, Illinois

    Disclosures

    Disclosure: Melissa Prest, DCN, RDN, has no relevant financial relationships.

  • Jessica Joseph, MBA

    Senior Vice President, Scientific Operations
    National Kidney Foundation
    New York, New York

    Disclosures

    Disclosure: Jessica Joseph, MBA, has no relevant financial relationships.

  • Kathryn Troy, MPH

    Senior Director, Continuing Education
    National Kidney Foundation
    New York, New York

    Disclosures

    Disclosure: Kathryn Troy, MPH, has no relevant financial relationships.

  • Jordan Cannon, MS

    Senior Director, Professional Programs and Member Engagement
    National Kidney Foundation
    New York, New York

    Disclosures

    Disclosure: Jordan Cannon, MS, has no relevant financial relationships.

Reviewer Disclosures

  • Bernard Jaar, MD

    Senior Staff Nephrologist
    Johns Hopkins University / Nephrology Center of Maryland
    Frederick, Maryland

    Disclosures

    Disclosure: Bernard Jaar, MD, has no relevant financial relationships.


Accreditation Statements


In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American.

Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the Commission on Dietetic Registration (CDR), and the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to provide continuing education for the healthcare team.

    For Physicians

  • The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The National Kidney Foundation designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Nurse Practitioner, Nurse and Dialysis Technician

    Awarded 1.5 contact hours of continuing nursing education (includes 0.25 contact hours in the area of pharmacology).

    Contact This Provider

    For Pharmacists

  • This knowledge-based enduring activity has been assigned Universal Activity Number (JA0004461-0000-22-043-H01-P), for 1.5 contact hours (0.15 CEUs). To receive credit, learners must read the activity overview, learning objectives and faculty disclosures, complete the pre-test, review the content, complete the post-test with a minimum score of 70% (post-test may be taken up to 3 times) and electronic activity evaluation. An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact [email protected] if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

    Contact This Provider

  • Physician Assistant

    National Kidney Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until Sept 21, 2023. PAs should only claim credit commensurate with the extent of their participation.

    Dietitian

    As a Jointly Accredited Organization, the National Kidney Foundation is approved to offer dietitian continuing education by the Commission on Dietetic Registration (CDR). Organizations, not individual courses, are approved under this program. Dietitians completing this course receive 1.5 continuing education credits.

    Social Worker

    As a Jointly Accredited Organization, the National Kidney Foundation is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. The National Kidney Foundation maintains responsibility for this course. Social workers completing this course receive 1.5 continuing education credits

    Licensed social workers should contact their individual jurisdiction to review current continuing education requirements for licensure renewal.

    Transplant Coordinator

    The National Kidney Foundation is accredited as a provider of continuing transplant education by the American Board for Transplant Certification: CEPTC Provider Number #170. This activity has been granted 1.5 contact hours. Program ID 170-XX.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Diagnosis and Optimal Treatment for Systemic Lupus Erythematosus and Lupus Nephritis

Authors: Salam Almanni, MD, MS; Dawn Caster, MD, FASN; Juan Mejia-Vilet, MD, MSc, PhDFaculty and Disclosures

CME / ABIM MOC / CE Released: 9/26/2022

Valid for credit through: 9/26/2023

processing....

Please answer the questions that appear during the activity: Choose an answer, scroll down, and click “Submit.” See responses, scroll down, and click “Continue.”